PCMA Statement on the Administration’s Proposed Medicare Part B Pricing Model
October 25, 2018
Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the Administration’s proposed Medicare Part B pricing model:...
PCMA Applauds the Administration for Enacting Legislation to Curb America’s Opioid Crisis
October 24, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) recognizes today’s enactment of historic legislation, the SUPPORT for Patients and Communities Act (H.R....
PCMA Statement on the Administration’s Proposal Requiring List Prices of Drugs in TV Ads
October 15, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department...
Join us for the year’s most important specialty pharmacy business conference. The event offers invaluable networking and education for individuals and companies involved in specialty drug benefit management including specialty pharmacies, PBMs, drug manufacturers, and others.
Learn MorePBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.